Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ScreenPro Building Cash Position With Continued Growth In Covid Testing Numbers

C.SCRN

Toronto, Ontario--(Newsfile Corp. - April 13, 2022) - ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report a significant increase in the Covid-19 testing numbers this year, which attributes to the Company's stronger cash position. Covid testing remains in high demand for the film and production industry. Due to the nature of the work environment, staff members are often operating in contained areas and in close proximity. With various highly contagious variants, such as Omicron and the numbers of infections increasing, we foresee more contracts throughout 2022.

The Company also faces a rise in demand for testing in the travel and tourism industry along with its concierge (home/office visit) services. In addition to the news release on March 24th, 2022, the Company has received three additional testing contracts in television and production dated as of April 8, 2022, resulting in a total of 21 new productions to date for Q1 of FY22.

Recent testing numbers are as follows:

  • December 2021 resulted in a total of 14,202 Covid-19 tests
  • January 2022 resulted in a total of 19,446 Covid-19 tests
  • February 2022 resulted in a total of 23,655 Covid-19 tests
  • March 2022 resulted in a total of 25,333 Covid-19 tests

"As Canada faces a spike in Covid-19 cases and a possible sixth wave, the Company continues to build momentum with the Covid testing business for the film and production industry. We have also increased our testing services in the travel industry to meet potential demand as more and more people are travelling internationally," said Michael Yeung, Chairman of the Company.

"The film industry is still feeling the strain of the pandemic and have to continuously turn to Covid testing to keep individuals safe whilst on set. As the need for Covid testing expands, and as more people travel, we are confident that our testing continues to yield great revenue and profitability. We also anticipate securing more contracts which will attribute to higher revenue and profit for our shareholders," said Lena Kozovski, CEO of the Company.

About ScreenPro

ScreenPro is a Screening and Medical Technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing and breast cancer screening solutions across Canada. In addition, ScreenPro has its own medical doctor and nursing professionals with on the ground support staff and transportation, with access to high quality PPEs to ensure that clients are protected in all aspects of their testing needs.

For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com.

For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.

Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For further information please contact:

Lena Kozovski, CEO
Email: investors@screenprosecurity.com

Forward-Looking Statements:

Certain statements contained in this news release may constitute forward‐looking information, including statements relating to expectations regarding the acquisition and business of Concierge Medical Consultants Inc. and the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.

###

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/120120